Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
Greece
In shortFrigoglass A.b.e.e. Βιομηχανια Ψυκτικων Θαλαμων is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -1.3% | 12/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -3.5% | 6/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -11.1% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -1.4% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.44× | 53/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.33× | 93/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 1.89× | 60/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -0.78× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 1.43 | 8/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 3.2% | 33/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 4 of 4 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 4 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 2 | 17/100 |
| Revenue growth volatility | 81.5% | 0/100 |
| Operating margin volatility | 5.0% | 64/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -96.2% | 0/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
European data comes from annual reports in ESEF format (since 2020). Industry and ticker are not provided by this source.
Annual figures as reported. Hover a bar or point for the exact value.
The last 4 fiscal years from the company's annual reports.
EUR millions; negative values in parentheses.
| Fiscal year | FY20 | FY21 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | 333,238 | 384,268 | 0 | 19 |
| Cost of revenue | 273,405 | 317,019 | 0 | 14 |
| Gross profit | 59,833 | 67,249 | 0 | 5.2 |
| Research & development | 2,853 | 2,477 | 0 | 0 |
| Operating income | 20,947 | 30,962 | (0.2) | (0.2) |
| Interest expense | 12,633 | 25,289 | 0 | 0.3 |
| Pre-tax income | 7,321 | 13,067 | (0.2) | (0.5) |
| Income tax | 16,228 | 12,468 | 0 | 0.1 |
| Net income | (15,947) | (5,675) | (0.2) | (0.7) |
| Diluted EPS | −€0.04 | −€0.02 | €0.00 | €0.01 |
1.43 Grey zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: filings.xbrl.org (ESEF). Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Apr 28, 2026